Galecteye Pharma ApS: Financial statements 2019
CVR: 38248243
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Galecteye Pharma ApS (CVR 38248243) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,000 and a net result of DKK -6,020 compared with DKK -11,050 the year before. Equity in the 2019 report amounted to DKK 14,777. The solvency ratio was 11.9%.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK -6,020
- Equity
- DKK 14,777
- Total Assets
- DKK 124,099
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -5 t. | -6 t. | 15 t. | - |
| 2018 | - | -10 t. | -11 t. | 21 t. | - |
| 2017 | - | -17 t. | -18 t. | 32 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Galecteye Pharma ApS has published its annual report for 2018. Gross profit came to DKK -10,040, and the net result was DKK -11,050.
About Galecteye Pharma ApS
Galecteye Pharma ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2016. The company has been dissolved on 14 March 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,280 compared with DKK -6,020 the year before. Equity in the 2020 report amounted to DKK 7,497.